Efficacy and Safety of Long-Term Treatment with Stiripentol in Children and Adults with Drug-Resistant Epilepsies: A Retrospective Cohort Study of 196 Patients

BACKGROUND: Stiripentol is an antiseizure medication with multiple potential mechanisms of action, indicated as adjunctive therapy in people with Dravet syndrome, whose seizures are not adequately controlled with clobazam and valproate. However, there are scattered data on its efficacy in other epil...

Descripción completa

Detalles Bibliográficos
Autores principales: Balestrini, Simona, Doccini, Viola, Boncristiano, Alessandra, Lenge, Matteo, De Masi, Salvatore, Guerrini, Renzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392664/
https://www.ncbi.nlm.nih.gov/pubmed/35680739
http://dx.doi.org/10.1007/s40801-022-00305-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392664/
https://www.ncbi.nlm.nih.gov/pubmed/35680739
http://dx.doi.org/10.1007/s40801-022-00305-7

Ejemplares similares